ARCHIVES

In Brief: NCI Scientist Accused Of Taking ‘Payoffs’ Forom Drug Firms; GM-CS Wins FDA Approval

This article is from The Cancer Letter archive.

Vol. 17 No. 11 | March 15, 1991

Download PDF Visit The Full Archive

Related Articles

Senate Debates $1.1 Trillion “Cromnibus” Bill That Includes a $150 Million Increase for NIH

December 12, 2014

Sen. Brown Introduces Bill on Clinical Trials Coverage

April 3, 2009

Bennett, Turner & Coleman Law Firm To Merge With Ropes & Gray

July 5, 2002

NCI, Six Centers Begin Feasibility Study Of Spiral CT For Lung Cancer Screening.

September 8, 2000

Pepper’s Legacy Included NCI, Other Biomedical Research

June 9, 1989

Panel To Take Up Issues In Grant/Peer Review System, Consider NCAB Membership Requirements

December 11, 1981